Korean J Gastroenterol.  2022 Nov;80(5):237-239. 10.4166/kjg.2022.126.

Therapeutic Response Prediction of Fecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome: In Terms of Gut Microbiota

• Kim DS

• KMID: 2536354
• DOI: http://doi.org/10.4166/kjg.2022.126

Reference

1. Thomson P, Núñez P, Quera R, Bay C. 2021; Gastrointestinal microbiome, what is behind faecal microbiota transplantation? New Microbes New Infect. 42:100898. DOI: 10.1016/j.nmni.2021.100898. PMID: 34168881. PMCID: PMC8207221.

2. Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. 2015; Role of the normal gut microbiota. World J Gastroenterol. 21:8787–8803. DOI: 10.3748/wjg.v21.i29.8787. PMID: 26269668. PMCID: PMC4528021.

3. Enck P, Mazurak N. 2018; Dysbiosis in functional bowel disorders. Ann Nutr Metab. 72:296–306. DOI: 10.1159/000488773. PMID: 29694952.

4. El-Salhy M, Hausken T, Hatlebakk JG. 2021; Current status of fecal microbiota transplantation for irritable bowel syndrome. Neurogastroenterol Motil. 33:e14157. DOI: 10.1111/nmo.14157. PMID: 34236740.

5. Vervier K, Moss S, Kumar N, et al. 2022; Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet. Gut. 71:1821–1830. DOI: 10.1136/gutjnl-2021-325177. PMID: 34810234. PMCID: PMC9380505.

6. Lee SY, Lee KJ, Kim SJ, Cho SW. 2009; Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion. 79:196–201. DOI: 10.1159/000211715. PMID: 19342860.

7. El-Salhy M, Kristoffersen AB, Valeur J, et al. 2022; Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome. Neurogastroenterol Motil. 34:e14200. DOI: 10.1111/nmo.14353. PMID: 35302268. PMCID: PMC9539588.

8. Holvoet T, Joossens M, Vázquez-Castellanos JF, et al. 2021; Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating: short- and long-term results from a placebo-controlled randomized trial. Gastroenterology. 160:145–157.e8. DOI: 10.1053/j.gastro.2020.07.013. PMID: 32681922.

9. Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. 2020; The genus alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol. 11:906. DOI: 10.3389/fimmu.2020.00906. PMID: 32582143. PMCID: PMC7296073.